by Raynovich Rod | Apr 21, 2016 | Biopharmaceuticals, Macro
Expect Modest Rally in Biotechs Through Q1 Earnings As of mid-day trading 1P EDT with flat NASDAQ Update at close: biotechs held onto gains despite a mild sell-off for the Dow and S&P with NASDAQ flat. Biogen (BIIB) gained a tad more up 5.16%. From here we’d...
by Raynovich Rod | Apr 8, 2016 | Biopharmaceuticals, Macro
Biotech Rally Loses Momentum But Still Up for the Week IBB up 3.37 % , XBI up 5.04% , XLV up 0.77% this week. Investors took profits today despite all of the media focus and renewed excitement for the long term potential of new blockbuster drugs. The rally began...
by Raynovich Rod | Mar 20, 2016 | Biopharmaceuticals, Macro
3/22/16…Update Biotech Rally Enters Fourth Day-Green Screen XBI up 7.34% Over Five Days to $52.49 Our new picks were up today: ABBV,BLUE, BMY,GILD. But Gilead Sciences (GILD) was down after hours as Merck (MRK) HCV patents were found valid in dispute. A jury...
by Raynovich Rod | Feb 24, 2016 | Biopharmaceuticals, Macro
Biotech Stocks Off Lows Tracking Crude and Energy sector… 11.45 a EST Can healthcare stocks uncouple from energy and macro? Individual biotech stocks look very tradable with green catching up with red. But biotech stocks defy fundamental analysis with current...
by Raynovich Rod | Feb 10, 2016 | 2025 Rayno Biopharmaceuticals Portfolio, Macro
Have we reached a tradeable bottom in the biotech bear market? Today’s tape showed good volume but gains faded late in session. NASDAQ up 0.35% XLV up 0.88%-healthcare is the leading sector The biotech market bounced back early today in a broad rally...
by Raynovich Rod | Dec 3, 2015 | Biopharmaceuticals, Macro
Biotech Sell-Off Stops Bear Market Rally After a strong November and a rally from October lows biotech stocks broke down today along with the overall market. Keep in mind that it has been a bear market rally with expectations of a seasonal move up. There are plenty of...
by Raynovich Rod | Jul 8, 2015 | Biopharmaceuticals, Macro
7/13/15 12N EDT Roller Coaster Market MACRO to sidelines A wave of optimism reverses concerns about China and Greece. China stocks have recovered because there is still growth potential. Although a Greek deal is not finalized the glass is half full again and a Grexit...
by Raynovich Rod | Jul 6, 2015 | Biopharmaceuticals, Macro
Update 7/8/15 12:10p EDT Strange Day with Computer Networks NYSE exchange is down and trading halted- all orders are cancelled. However stocks are trading on other exchanges but at very low volume. United Airlines Grounding Ends after two hour disruption due to a...
by Raynovich Rod | Mar 10, 2015 | 2025 Rayno Biopharmaceuticals Portfolio, Biopharmaceuticals, Macro
Stocks in Sharp Sell-Off on Potential FED Rate Increase and Strong Dollar Deflation is Still Lurking S&P Down 1.7%, NASDAQ down 1.67% Biotech stocks avoided the severe sell-off today apparently immune to the strong dollar, flat earnings growth and FED interest...
by Raynovich Rod | Jan 15, 2015 | Biopharmaceuticals, Macro
Update Next Day…Green Screen in Biotech…1/16…Complete reversal all up XBI at $197.95 UP 3% AGIO up 3.6%, BLUE up 4.78%, JUNO up 12.4%, KITE up 10.2%, NLNK up 2.4%, PBYI up 9.4%, ZIOP up 1.76% Red Screen Day in Biotech NASDAQ 4584 down 1.18% Euro...
